Your browser doesn't support javascript.
loading
Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy.
Cabel, Luc; Proudhon, Charlotte; Romano, Emanuela; Girard, Nicolas; Lantz, Olivier; Stern, Marc-Henri; Pierga, Jean-Yves; Bidard, François-Clément.
Affiliation
  • Cabel L; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France.
  • Proudhon C; Versailles Saint Quentin en Yvelines University, Paris Saclay University, Saint Cloud, Paris, France.
  • Romano E; Circulating Tumor Biomarkers Laboratory, Institut Curie, PSL Research University, Paris, France.
  • Girard N; Circulating Tumor Biomarkers Laboratory, Institut Curie, PSL Research University, Paris, France.
  • Lantz O; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France.
  • Stern MH; INSERM U932, Institut Curie, PSL Research University, Paris, France.
  • Pierga JY; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France.
  • Bidard FC; INSERM U932, Institut Curie, PSL Research University, Paris, France.
Nat Rev Clin Oncol ; 15(10): 639-650, 2018 10.
Article in En | MEDLINE | ID: mdl-30050094

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Circulating Tumor DNA / Immunotherapy / Neoplasms Type of study: Screening_studies Limits: Humans Language: En Journal: Nat Rev Clin Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Circulating Tumor DNA / Immunotherapy / Neoplasms Type of study: Screening_studies Limits: Humans Language: En Journal: Nat Rev Clin Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Country of publication: